CLINICAL_TRIALS
trial_result
· 2024-06-20
Clinical Trial Update: A Study of Lenvatinib Plus Nivolumab in Participants With Hepatocellular Carcinoma [Phase 1]
Summary
Phase 1 study of lenvatinib plus nivolumab in hepatocellular carcinoma has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eisai Co., Ltd. | Conditions: Carcinoma, Hepatocellular | Phase 1 | Status: COMPLETED | Results posted: 2024-06-20